Purple Biotech Ltd. (PPBT)
USD 3.61
(-7.91%)
USD 3.61
(-7.91%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | -910 Thousand | -320 Thousand | 1 Million | 1 Million | 1 Million |
| Cost of Revenue | 196 Thousand | 201 Thousand | 231 Thousand | 235 Thousand | 80.00 | - |
| Gross Profit | -196 Thousand | -1.11 Million | -551 Thousand | 765 Thousand | 999.92 Thousand | 1 Million |
| Operating Expenses | -22.46 Million | 22.6 Million | 17.93 Million | 13.79 Million | 8.75 Million | 8.82 Million |
| Selling, General and Administrative Expenses | 5.04 Million | 6.28 Million | 6.1 Million | 6.3 Million | 6.07 Million | 4.45 Million |
| Research and Development Expenses | 17.03 Million | 16.32 Million | 11.82 Million | 7.48 Million | 2.67 Million | 5.26 Million |
| Other Expenses | -44.54 Million | - | - | -15.65 Million | -216 Thousand | - |
| Cost and Expenses | -22.27 Million | 22.6 Million | 17.93 Million | 13.79 Million | 8.75 Million | 8.82 Million |
| Operating Income | 22.27 Million | -22.6 Million | -17.93 Million | 12.61 Million | -7.15 Million | -7.82 Million |
| Interest Expense | 2.18 Million | 126 Thousand | 212 Thousand | 61 Thousand | 181 Thousand | 576 Thousand |
| Income Tax Expense | - | -935 Thousand | 637 Thousand | -15.66 Million | 216 Thousand | -2.62 Million |
| Earnings before Tax | -19.97 Million | -21.76 Million | -17.82 Million | -28.07 Million | -5.89 Million | -5.56 Million |
| Net Income | -19.88 Million | -20.82 Million | -18.46 Million | -12.4 Million | -6.1 Million | -5.2 Million |
| Earnings Per Share Basic | -0.09 | -1.13 | -1.04 | -0.72 | -3.15 | -0.27 |
| Earnings Per Share Diluted | -0.09 | -1.13 | -1.04 | -0.72 | -3.15 | -0.27 |
| Weighted Average Shares Outstanding | 221.33 Million | 18.48 Million | 17.8 Million | 17.21 Million | 1.93 Million | 19.54 Million |
| Weighted Average Shares Outstanding (Diluted) | 221.33 Million | 18.48 Million | 17.8 Million | 17.21 Million | 1.93 Million | 19.54 Million |
| Gross Margin | - | 1.22 | 1.72 | 0.76 | 1.00 | 1.00 |
| EBIT Margin | - | 23.55 | 54.32 | -27.96 | -7.64 | -7.73 |
| Profit Margin | - | 22.88 | 57.70 | -12.40 | -6.11 | -5.20 |
| EBITDA | -22.22 Million | -21.49 Million | -17.51 Million | -28.41 Million | -6.13 Million | -5.55 Million |
| Earnings Before Tax Margin | - | 24.84 | 56.04 | 12.61 | -7.16 | -7.83 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 48.99 Thousand | 48 Thousand | 48 Thousand | 199 Thousand | 50 Thousand | 53 Thousand |
| Gross Profit | -48.99 Thousand | -48 Thousand | -48 Thousand | -199 Thousand | -50 Thousand | -53 Thousand |
| Operating Expenses | 3.4 Million | 4.41 Million | 6.21 Million | 22.07 Million | 5.74 Million | 5.13 Million |
| Selling, General and Administrative Expenses | 816 Thousand | 995 Thousand | 977 Thousand | - | 1.15 Million | 1.43 Million |
| Research and Development Expenses | 2.39 Million | 3.42 Million | 5.24 Million | - | 4.58 Million | 3.7 Million |
| Other Expenses | -202 Thousand | - | - | - | - | - |
| Cost and Expenses | 3.45 Million | 4.46 Million | 6.26 Million | 22.27 Million | 5.74 Million | 5.13 Million |
| Operating Income | -3.45 Million | -4.46 Million | -6.26 Million | -22.27 Million | -5.74 Million | 5.13 Million |
| Interest Expense | 24 Thousand | 17 Thousand | 1.97 Million | 2.18 Million | 16 Thousand | 148 Thousand |
| Income Tax Expense | -9999.00 | -19 Thousand | -31 Thousand | -97 Thousand | 689 Thousand | -10.16 Million |
| Earnings before Tax | -2.41 Million | -3.78 Million | -4.85 Million | -19.97 Million | -5.05 Million | -5.16 Million |
| Net Income | -2.4 Million | -3.76 Million | -4.82 Million | -19.88 Million | -5.03 Million | -5.13 Million |
| Earnings Per Share Basic | -0.09 | -0.15 | -0.20 | - | -0.24 | -0.24 |
| Earnings Per Share Diluted | -0.09 | -0.15 | -0.20 | - | -0.24 | -0.24 |
| Weighted Average Shares Outstanding | 27.66 Million | 25.93 Million | 24.61 Million | 24.61 Million | 21.41 Million | 21.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 27.66 Million | 25.93 Million | 24.61 Million | 24.61 Million | 21.41 Million | 21.01 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -3.4 Million | -4.41 Million | -6.21 Million | - | -4.98 Million | -4.95 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
VMTG
9578
NDLVENTURE
XTC
MSPL
PLAKR